AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

No trades
See on Supercharts
Market capitalization
‪371.68 B‬USD
1.80USD
‪3.76 B‬USD
‪50.04 B‬USD
Beta (1Y)
0.03

About AbbVie Inc.


CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
ISIN
ARBCOM4603M9
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Check out other big names from the same industry as ABBVD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ABBV6009613
AbbVie Inc. 5.6% 15-MAR-2055
Yield to maturity
Maturity date
Mar 15, 2055
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049
Yield to maturity
Maturity date
Nov 21, 2049
ABBV5759202
AbbVie Inc. 4.95% 15-MAR-2031
Yield to maturity
Maturity date
Mar 15, 2031
ABBV5068388
AbbVie Inc. 4.625% 01-OCT-2042
Yield to maturity
Maturity date
Oct 1, 2042
ABBV6009612
AbbVie Inc. 4.875% 15-MAR-2030
Yield to maturity
Maturity date
Mar 15, 2030
ABBV5759203
AbbVie Inc. 5.05% 15-MAR-2034
Yield to maturity
Maturity date
Mar 15, 2034
ABBV5758813
AbbVie Inc. 4.8% 15-MAR-2027
Yield to maturity
Maturity date
Mar 15, 2027
ABBV6009611
AbbVie Inc. 4.65% 15-MAR-2028
Yield to maturity
Maturity date
Mar 15, 2028
ABBV5759204
AbbVie Inc. 5.35% 15-MAR-2044
Yield to maturity
Maturity date
Mar 15, 2044
ABBV5068386
AbbVie Inc. 4.05% 21-NOV-2039
Yield to maturity
Maturity date
Nov 21, 2039
ABBV5068389
AbbVie Inc. 4.85% 15-JUN-2044
Yield to maturity
Maturity date
Jun 15, 2044

See all ABBVD bonds